Consideration of allosterism and interacting proteins in the physiological functions of the serotonin transporter

Biochemical Pharmacology

Volumn 83, Issue 4, 2012, Pages 435-442

  Zhong, Huailing ^a   Sánchez, Connie ^b   Caron, Marc G ^c  

^a U Pharm Laboratories LLC   (United States)

^b LUNDBECK RESEARCH USA   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Allosteric; Escitalopram (S citalopram); Selective serotonin reuptake inhibitor (SSRI); Serotonin (5 HT); Serotonin transporter (SERT); SERT interacting proteins (SIPs)

Indexed keywords

CITALOPRAM; ESCITALOPRAM; HYDROGEN PEROXIDE; MARCKS PROTEIN; MYOSIN; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN TRANSPORTER; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN INTERACTING WITH PROTEIN KINASE C; SEROTONIN; SEROTONIN TRANSPORTER; SYNTAXIN 1A;

AFFINITY CHROMATOGRAPHY; ALLOSTERISM; BINDING SITE; BIOLOGY; BRAIN; CRYSTAL STRUCTURE; GENE SILENCING; HIPPOCAMPUS; HUMAN; KNOCKOUT MOUSE; MUTATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

EID: 84855759792     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.020     Document Type: Note

References (76)

1. P. Blier, and C. De Montigny Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders Neuropsychopharmacology 21 1999 91S 98S (Pubitemid 29396476)
2. U. Boer, C. Noll, I. Cierny, D. Krause, C. Hiemke, and W. Knepel A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice Eur J Pharmacol 633 2010 33 38
3. B.G. Bunney, and W.E. Bunney Rapid-acting antidepressant strategies: mechanisms of action Int J Neuropsychopharmacol 2011 1 19
4. J.P. Changeux, and S.J. Edelstein Allosteric mechanisms of signal transduction Science 308 2005 1424 1428 (Pubitemid 40791288)
5. T. Kenakin Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors Trends Pharmacol Sci 28 2007 407 415 (Pubitemid 47087972)
6. Z.G. Gao, and K.A. Jacobson Keynote review: allosterism in membrane receptors Drug Discov Today 11 2006 191 202
7. L.P. Wennogle, and L.R. Meyerson Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites Eur J Pharmacol 86 1982 303 307 (Pubitemid 13220934)
8. P. Plenge, and E.T. Mellerup An affinity-modulating site on neuronal monoamine transport proteins Pharmacol Toxicol 80 1997 197 201 (Pubitemid 27168868)
9. M.J. Millan Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application Pharmacol Ther 110 2006 135 370
10. A. Nandi, C.M. Dersch, M. Kulshrestha, S. Ananthan, and R.B. Rothman Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter Synapse 53 2004 176 183 (Pubitemid 38971896)
11. B. Nightingale, C.M. Dersch, T.L. Boos, E. Greiner, W.J. Calhoun, and A.E. Jacobson Studies of the biogenic amine transporters: XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter J Pharmacol Exp Ther 314 2005 906 915 (Pubitemid 41043877)
12. C. Sanchez, K.P. Bogeso, B. Ebert, E.H. Reines, and C. Braestrup Escitalopram versus citalopram: the surprising role of the R-enantiomer Psychopharmacology (Berl) 174 2004 163 176 (Pubitemid 38916289)
13. H. Zhong, K.B. Hansen, N.J. Boyle, K. Han, G. Muske, and X. Huang An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant Neurosci Lett 462 2009 207 212
14. C. Sanchez The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram Basic Clin Pharmacol Toxicol 99 2006 91 95 (Pubitemid 44213936)
15. M. El Mansari, C. Sanchez, G. Chouvet, B. Renaud, and N. Haddjeri Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain Neuropsychopharmacology 30 2005 1269 1277 (Pubitemid 40848081)
16. O. Mnie-Filali, C. Faure, M. El Mansari, L. Lambas-Senas, A. Berod, and L. Zimmer R-citalopram prevents the neuronal adaptive changes induced by escitalopram Neuroreport 18 2007 1553 1556 (Pubitemid 47476382)
17. A. Mork, M. Kreilgaard, and C. Sanchez The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats Neuropharmacology 45 2003 167 173 (Pubitemid 36782529)
18. S. Storustovu, C. Sanchez, P. Porzgen, L.T. Brennum, A.K. Larsen, and M. Pulis R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter Br J Pharmacol 142 2004 172 180 (Pubitemid 38698206)
19. C. Sanchez, P. Gruca, and M. Papp R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model Behav Pharmacol 14 2003 465 470 (Pubitemid 37176804)
20. M. El Mansari, O. Wiborg, O. Mnie-Filali, N. Benturquia, C. Sanchez, and N. Haddjeri Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies Int J Neuropsychopharmacol 10 2007 31 40 (Pubitemid 46122750)
21. F. Chen, M.B. Larsen, H.A. Neubauer, C. Sanchez, P. Plenge, and O. Wiborg Characterization of an allosteric citalopram-binding site at the serotonin transporter J Neurochem 92 2005 21 28 (Pubitemid 40193506)
22. F. Chen, M.B. Larsen, C. Sanchez, and O. Wiborg The S-enantiomer of R, S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors Eur Neuropsychopharmacol 15 2005 193 198 (Pubitemid 40193425)
23. L. Tanum, L.P. Strand, and H. Refsum Serum concentrations of citalopram-dose-dependent variation in R- and S-enantiomer ratios Pharmacopsychiatry 43 2010 190 193
24. S.K. Singh, A. Yamashita, and E. Gouaux Antidepressant binding site in a bacterial homologue of neurotransmitter transporters Nature 448 2007 952 956 (Pubitemid 47312772)
25. Z. Zhou, J. Zhen, N.K. Karpowich, R.M. Goetz, C.J. Law, and M.E. Reith LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake Science 317 2007 1390 1393 (Pubitemid 47417479)
26. C. Sur, H. Betz, and P. Schloss A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter Proc Natl Acad Sci U S A 94 1997 7639 7644 (Pubitemid 27345369)
27. L.K. Henry, J.R. Field, E.M. Adkins, M.L. Parnas, R.A. Vaughan, and M.F. Zou Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants J Biol Chem 281 2006 2012 2023 (Pubitemid 43845789)
28. J. Andersen, L. Olsen, K.B. Hansen, O. Taboureau, F.S. Jorgensen, and A.M. Jorgensen Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter J Biol Chem 285 2010 2051 2063
29. H. Koldso, K. Severinsen, T.T. Tran, L. Celik, H.H. Jensen, and O. Wiborg The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations J Am Chem Soc 132 2010 1311 1322
30. J. Andersen, O. Taboureau, K.B. Hansen, L. Olsen, J. Egebjerg, and K. Stromgaard Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants J Biol Chem 284 2009 10276 10284
31. H.A. Neubauer, C.G. Hansen, and O. Wiborg Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study Mol Pharmacol 69 2006 1242 1250
32. C.J. Loland, P. Plenge, L. Shi, P. Zhang, J.A. Javitch, and A.H. Newman Mapping of the allosteric binding site in the serotonin transporter Basic Clin Pharmacol Toxicol 107 2010 116 117
33. R.D. Blakely, S. Ramamoorthy, S. Schroeter, Y. Qian, S. Apparsundaram, and A. Galli Regulated phosphorylation and trafficking of antidepressant- sensitive serotonin transporter proteins Biol Psychiatry 44 1998 169 178 (Pubitemid 28378299)
34. G.E. Torres, W.D. Yao, A.R. Mohn, H. Quan, K.M. Kim, and A.I. Levey Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1 Neuron 30 2001 121 134 (Pubitemid 32441681)
35. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems Pharmacol Ther 92 2001 21 55 (Pubitemid 34032021)
36. J. Haase, A.M. Killian, F. Magnani, and C. Williams Regulation of the serotonin transporter by interacting proteins Biochem Soc Trans 29 2001 722 728 (Pubitemid 33131769)
37. J.A. Steiner, A.M. Carneiro, and R.D. Blakely Going with the flow: trafficking-dependent and -independent regulation of serotonin transport Traffic 9 2008 1393 1402
38. C. Wersinger, M. Rusnak, and A. Sidhu Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein Eur J Neurosci 24 2006 55 64 (Pubitemid 44050666)
39. C. Wersinger, and A. Sidhu Partial regulation of serotonin transporter function by gamma-synuclein Neurosci Lett 453 2009 157 161
40. H.K. Muller, O. Wiborg, and J. Haase Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2 J Biol Chem 281 2006 28901 28909 (Pubitemid 44507033)
41. B. Chanrion, C.C. Mannoury la, F. Bertaso, M. Lerner-Natoli, M. Freissmuth, and M.J. Millan Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity Proc Natl Acad Sci U S A 104 2007 8119 8124 (Pubitemid 47185885)
42. J. Rizo, and C. Rosenmund Synaptic vesicle fusion Nat Struct Mol Biol 15 2008 665 674 (Pubitemid 351932007)
43. M.W. Quick Regulating the conducting states of a mammalian serotonin transporter Neuron 40 2003 537 549 (Pubitemid 37494703)
44. M.A. Ciccone, M. Timmons, A. Phillips, and M.W. Quick Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A Neuropharmacology 55 2008 763 770
45. P.J. Blackshear The MARCKS family of cellular protein kinase C substrates J Biol Chem 268 1993 1501 1504 (Pubitemid 23033530)
46. U. Jess, F.O. El, J. Kirsch, and H. Betz Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C Biochem Biophys Res Commun 294 2002 272 279 (Pubitemid 34694089)
47. H. Mochizuki, T. Amano, T. Seki, H. Matsubayashi, C. Mitsuhata, and K. Morita Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT) Neurochem Int 46 2005 93 105 (Pubitemid 41556617)
48. K. Clark, M. Langeslag, C.G. Figdor, and F.N. van Leeuwen Myosin II and mechanotransduction: a balancing act Trends Cell Biol 17 2007 178 186 (Pubitemid 46507805)
49. V. Betapudi Myosin II motor proteins with different functions determine the fate of lamellipodia extension during cell spreading PLoS One 5 2010 e8560
50. D. Ozaslan, S. Wang, B.A. Ahmed, A.M. Kocabas, J.C. McCastlain, and A. Bene Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues J Biol Chem 278 2003 43991 44000 (Pubitemid 37377138)
51. K.K. Dev PDZ domain protein-protein interactions: a case study with PICK1 Curr Top Med Chem 7 2007 3 20 (Pubitemid 46062394)
52. J.G. Hanley PICK1: a multi-talented modulator of AMPA receptor trafficking Pharmacol Ther 118 2008 152 160
53. T.S. Thorsen, K.L. Madsen, N. Rebola, M. Rathje, V. Anggono, and A. Bach Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD Proc Natl Acad Sci U S A 107 2010 413 418
54. M.D. Heitzer, and D.B. DeFranco Hic-5, an adaptor-like nuclear receptor coactivator Nucl Recept Signal 4 2006 e019
55. J. Caltagarone, R.L. Hamilton, G. Murdoch, Z. Jing, D.B. DeFranco, and R. Bowser Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi J Neuropathol Exp Neurol 69 2010 356 371
56. A.M. Carneiro, S.L. Ingram, J.M. Beaulieu, A. Sweeney, S.G. Amara, and S.M. Thomas The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter J Neurosci 22 2002 7045 7054 (Pubitemid 35385611)
57. A.M. Carneiro, and R.D. Blakely Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter J Biol Chem 281 2006 24769 24780 (Pubitemid 44274251)
58. M.G. Spillantini, and M. Goedert The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy Ann N Y Acad Sci 920 2000 16 27 (Pubitemid 32056547)
59. B.I. Giasson, J.E. Duda, M.S. Forman, V.M. Lee, and J.Q. Trojanowski Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons Exp Neurol 172 2001 354 362 (Pubitemid 34075084)
60. A.H. Schonthal Role of serine/threonine protein phosphatase 2A in cancer Cancer Lett 170 2001 1 13 (Pubitemid 32607654)
61. J.A. Steiner, A.M. Carneiro, J. Wright, H.J. Matthies, H.C. Prasad, and C.K. Nicki cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake Mol Brain 2 2009 26
62. C.B. Zhu, K.M. Lindler, N.G. Campbell, J.S. Sutcliffe, W.A. Hewlett, and R.D. Blakely Colocalization and regulated physical association of presynaptic serotonin transporters with A3 adenosine receptors Mol Pharmacol 80 2011 458 465
63. R. Ramakrishnan, R. Sheeladevi, and A. Namasivayam Regulation of protein kinases and coregulatory interplay of S-100beta and serotonin transporter on serotonin levels in diabetic rat brain J Neurosci Res 87 2009 246 259
64. + exchanger NHE5 J Biol Chem 284 2009 13892 13903
65. L. Liu, H. Liao, A. Castle, J. Zhang, J. Casanova, and G. Szabo SCAMP2 interacts with Arf6 and phospholipase D1 and links their function to exocytotic fusion pore formation in PC12 cells Mol Biol Cell 16 2005 4463 4472 (Pubitemid 41416433)
66. L. Zhou, and D.Y. Zhu Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications Nitric Oxide 20 2009 223 230
67. M.E. Cusick, N. Klitgord, M. Vidal, and D.E. Hill Interactome: gateway into systems biology Hum Mol Genet 14 2005 R171 R181
68. H.C. Prasad, J.A. Steiner, J.S. Sutcliffe, and R.D. Blakely Enhanced activity of human serotonin transporter variants associated with autism Philos Trans R Soc Lond B Biol Sci 364 2009 163 173
69. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat Rev Drug Discov 8 2009 41 54
70. P. Keov, P.M. Sexton, and A. Christopoulos Allosteric modulation of G protein-coupled receptors: a pharmacological perspective Neuropharmacology 60 2011 24 35
71. S.P. Arneric, M. Holladay, and M. Williams Neuronal nicotinic receptors: a perspective on two decades of drug discovery research Biochem Pharmacol 74 2007 1092 1101 (Pubitemid 47417924)
72. A. Pandya, and J.L. Yakel Allosteric modulators of the alpha4beta2 subtype of neuronal nicotinic acetylcholine receptors Biochem Pharmacol 82 2011 952 958
73. T.L. Wallace, and R.H. Porter Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease Biochem Pharmacol 82 2011 891 903
74. K. Bøgesø, P. Bregnedal, K. Juhl, H. Zhong, and O. Wiborg New naphthalene derivatives of citalopram discriminate between the primary and the allosteric binding sites at the human serotonin transporter Basic Clin Pharmacol Toxicol 107 2010 210
75. B.J. Thompson, T. Jessen, L.K. Henry, J.R. Field, K.L. Gamble, and P.J. Gresch Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter Proc Natl Acad Sci U S A 108 2011 3785 3790
76. M.J. Owens C.20.01 New pharmacological tools in evaluation of antidepressant molecules Eur Neuropsychopharmacol 17 2007 S610